Marla Lipsyc-Sharf

10PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersMolecular targetsHealth and ecological risk assessmentCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 13, 2026
Current Management of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in a Changing Landscape.

|Jul 13, 2026
Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial.

|Nov 07, 2025
Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer.

Maxwell R Lloyd, Caroline M Weipert, Azka Ali

|Sep 09, 2025
Pregnancy and breast cancer in young women: current updates and future directions.

Shiliang Zhang, Sena B Guclu, Marla Lipsyc-Sharf

|Jan 08, 2024
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer.

Stefania Morganti, Christopher J Gibson, Qingchun Jin

|Jun 26, 2023
Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab.

Marla Lipsyc-Sharf, Esha Jain, Laura C Collins

Pageof 2

Frequent Collaborators

3 joint publications

Sara M Tolaney

3 joint publications

Heather Parsons

3 joint publications

Ann Partridge

2 joint publications

Katheryn Santos